Riddle, M. C. et al. Monogenic diabetes: from genetic insights to population-based precision in care. reflections from a diabetes care editors’ expert forum. Diabetes Care 43, 3117–3128 (2020).
Article PubMed PubMed Central Google Scholar
Froguel, P. et al. Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus. Nature 356, 162–164 (1992).
Article CAS PubMed Google Scholar
Vionnet, N. et al. Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus. Nature 356, 721–722 (1992). Study identifying pathogenic mutations in GCK as leading to one of the most prevalent forms of monogenic diabetes.
Article CAS PubMed Google Scholar
American Diabetes Association Professional Practice Committee. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes — 2022. Diabetes Care 45 (Suppl. 1), S17–S38 (2022).
Bonnefond, A. et al. Pathogenic variants in actionable MODY genes are associated with type 2 diabetes. Nat. Metab. 2, 1126–1134 (2020). A study that highlights the incomplete penetrance of pathogenic mutations in monogenic diabetes genes, which are even found in patients with suspected typical T2DM.
Article CAS PubMed Google Scholar
Ahlqvist, E. et al. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol. 6, 361–369 (2018).
Bonnefond, A. & Froguel, P. Clustering for a better prediction of type 2 diabetes mellitus. Nat. Rev. Endocrinol. 17, 193–194 (2021).
Yang, Y. & Chan, L. Monogenic diabetes: what it teaches us on the common forms of type 1 and type 2 diabetes. Endocr. Rev. 37, 190–222 (2016).
Article PubMed PubMed Central Google Scholar
Vaxillaire, M., Froguel, P. & Bonnefond, A. How recent advances in genomics improve precision diagnosis and personalized care of maturity-onset diabetes of the young. Curr. Diabetes Rep. 19, 79 (2019).
Shields, B. M. et al. Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia 53, 2504–2508 (2010).
Article CAS PubMed Google Scholar
Donath, X. et al. Next-generation sequencing identifies monogenic diabetes in 16% of patients with late adolescence/adult-onset diabetes selected on a clinical basis: a cross-sectional analysis. BMC Med. 17, 132 (2019).
Article PubMed PubMed Central Google Scholar
Vaxillaire, M. et al. Monogenic diabetes characteristics in a transnational multicenter study from Mediterranean countries. Diabetes Res. Clin. Pract. 171, 108553 (2021).
Article CAS PubMed Google Scholar
Mohan, V. et al. Comprehensive genomic analysis identifies pathogenic variants in maturity-onset diabetes of the young (MODY) patients in South India. BMC Med. Genet. 19, 22 (2018).
Article PubMed PubMed Central Google Scholar
Park, S. S. et al. Identifying pathogenic variants of monogenic diabetes using targeted panel sequencing in an East Asian population. J. Clin. Endocrinol. Metab. https://doi.org/10.1210/jc.2018-02397 (2019).
Article PubMed PubMed Central Google Scholar
Breidbart, E. et al. Frequency and characterization of mutations in genes in a large cohort of patients referred to MODY registry. J. Pediatr. Endocrinol. Metab. 34, 633–638 (2021).
Article CAS PubMed PubMed Central Google Scholar
Pezzilli, S. et al. Pathogenic variants of MODY-genes in adult patients with early-onset type 2 diabetes. Acta Diabetol. 59, 747–750 (2022).
Article CAS PubMed Google Scholar
Flannick, J. et al. Assessing the phenotypic effects in the general population of rare variants in genes for a dominant Mendelian form of diabetes. Nat. Genet. 45, 1380–1385 (2013).
Article CAS PubMed PubMed Central Google Scholar
Mirshahi, U. L. et al. Reduced penetrance of MODY-associated HNF1A/HNF4A variants but not GCK variants in clinically unselected cohorts. Am. J. Hum. Genet. 109, 2018–2028 (2022).
Article CAS PubMed PubMed Central Google Scholar
Da Silva Xavier, G. The cells of the islets of Langerhans. J. Clin. Med. 7, E54 (2018).
Yamagata, K. et al. Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3). Nature 384, 455–458 (1996). Study identifying pathogenic mutations in HNF1A as leading to one of the most prevalent forms of monogenic diabetes.
Article CAS PubMed Google Scholar
Yamagata, K. et al. Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1). Nature 384, 458–460 (1996).
Article CAS PubMed Google Scholar
Raeder, H. et al. Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction. Nat. Genet. 38, 54–62 (2006).
Article CAS PubMed Google Scholar
Malikova, J. et al. Functional analyses of HNF1A-MODY variants refine the interpretation of identified sequence variants. J. Clin. Endocrinol. Metab. 105, dgaa051 (2020).
Li, L.-M., Jiang, B.-G. & Sun, L.-L. HNF1A: from monogenic diabetes to type 2 diabetes and gestational diabetes mellitus. Front. Endocrinol. 13, 829565 (2022).
Bonnefond, A. et al. GATA6 inactivating mutations are associated with heart defects and, inconsistently, with pancreatic agenesis and diabetes. Diabetologia 55, 2845–2847 (2012).
Article CAS PubMed Google Scholar
Jonsson, J., Carlsson, L., Edlund, T. & Edlund, H. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 371, 606–609 (1994).
Article CAS PubMed Google Scholar
Duque, M., Amorim, J. P. & Bessa, J. Ptf1a function and transcriptional cis-regulation, a cornerstone in vertebrate pancreas development. FEBS J. 289, 5121–5136 (2022).
Article CAS PubMed Google Scholar
Tiyaboonchai, A. et al. GATA6 plays an important role in the induction of human definitive endoderm, development of the pancreas, and functionality of pancreatic β cells. Stem Cell Rep. 8, 589–604 (2017).
Rouzier, C. et al. A novel CISD2 mutation associated with a classical Wolfram syndrome phenotype alters Ca2+ homeostasis and ER-mitochondria interactions. Hum. Mol. Genet. 26, 1599–1611 (2017).
Article CAS PubMed PubMed Central Google Scholar
Shrestha, N., De Franco, E., Arvan, P. & Cnop, M. Pathological β-cell endoplasmic reticulum stress in type 2 diabetes: current evidence. Front. Endocrinol. 12, 650158 (2021).
Graff, S. M. et al. A KCNK16 mutation causing TALK-1 gain-of-function is associated with maturity-onset diabetes of the young. JCI Insight 6, e138057 (2021).
Article PubMed PubMed Central Google Scholar
Santer, R. et al. Mutations in GLUT2, the gene for the liver-type glucose transporter, in patients with Fanconi-Bickel syndrome. Nat. Genet. 17, 324–326 (1997).
Article CAS PubMed Google Scholar
Labay, V. et al. Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness. Nat. Genet. 22, 300–304 (1999).
Article CAS PubMed Google Scholar
Jungtrakoon, P. et al. Loss-of-function mutation in thiamine transporter 1 in a family with autosomal dominant diabetes. Diabetes 68, 1084–1093 (2019).
Article CAS PubMed PubMed Central Google Scholar
Mancuso, M. et al. The m.3243A>G mitochondrial DNA mutation and related phenotypes. A matter of gender? J. Neurol. 261, 504–510 (2014).
Article CAS PubMed Google Scholar
Pickett, S. J. et al. Phenotypic heterogeneity in m.3243A>G mitochondrial disease: the role of nuclear factors. Ann. Clin. Transl. Neurol. 5, 333–345 (2018).
Article CAS PubMed PubMed Central Google Scholar
Vaxillaire, M. & Froguel, P. Monogenic diabetes in the young, pharmacogenetics and relevance to multifactorial forms of type 2 diabetes. Endocr. Rev. 29, 254–264 (2008).
Article CAS PubMed Google Scholar
Raimondo, A. et al. Phenotypic severity of homozygous GCK mutations causing neonatal or childhood-onset diabetes is primarily mediated through effects on protein stability. Hum. Mol. Genet. 23, 6432–6440 (2014).
Article CAS PubMed PubMed Central Google Scholar
Rees, M. G. et al. A panel of diverse assays to interrogate the interaction between glucokinase and glucokinase regulatory protein, two vital proteins in human disease. PLoS ONE 9, e89335 (2014).
留言 (0)